|
| Exchange Received Time 13/12/2018 11:01:57 Exchange Disseminated Time 13/12/2018 11:02:05 Time Taken 00:00:08 | Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a team of Fund Managers and Research Analysts of Malabar Investments would be having a meeting with Dr. A. Velumani, Chairman, Managing Director & CEO, Mr. Anand Velumani, Director of our wholly owned subsidiary, Nueclear Healthcare Limited, Dr. Caesar Sengupta, Vice-President-Operations and Mr. Sachin Salvi, General Manager-Finance, at our office by 11.00 A.M. on Monday, December 17, 2018.
Please note that there could be last minute change in the timings or in the names of our officers the analysts would be meeting.
Please note that no un-published Price-Sensitive Information will be shared during the above meeting.
|
|
|